#ACR21 Abst#0916 ⭐️AxSpa pts in remission: Full Certolizumab vs 1/2 dose vs PBO ▶️ 85% w/o flare in full dose, 80% in 1/2 dose, just 23% in PBO ▶️ PBO pts with NO flare STILL showed ⬆️ ASDAS, BASDAI, and CRP 🔥Would ⬇️ not d/c Cimzia! @Rheumnow https://t.co/uc5JDVY0ud #ACRBest https://t.co/fOssPlTEwR